Perrigo Ordinary Shares reported $604.4M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8383M 448M
Abbvie ABBV:US $ 10036M 518M
Aphria Inc APH:CN C$ 221.95M 18.21M
Bayer BAYN:GR 9.25B 3.88B
Bristol Myers Squibb BMY:US $ 9.63B 360M
Catalent CTLT:US $ 891M 46.7M
Coherus Biosciences CHRS:US $ 115.29M 3.48M
Corcept Therapeutics CORT:US $ 59.9M 254K
Dr.Reddys Laboratories DRRD:IN 47.21B 2.27B
Eli Lilly And LLY:US $ 5296.8M 39.9M
Endo International Ordinary Shares ENDP:US $ 682.87M 112.15M
Flexion Therapeutics FLXN:US $ 44.98M 73K
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Horizon Pharma HZNP:US $ 705.45M 11.42M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Lannett LCI:US $ 109.67M 30.16M
Merk MRK:US $ 8328M 1460M
Pacira Pharmaceuticals PCRX:US $ 96.29M 4.46M
Perrigo Ordinary Shares PRGO:US $ 604.4M 502.6M
Pfizer PFE:US $ 16447M 3384M
Phibro Animal Health PAHC:US $ 200.05M 1.07M
Prestige Brands PBH:US $ 199.79M 21.95M
Supernus Pharmaceuticals SUPN:US $ 115.86M 8.64M
Teva Pharmaceutical TEVA:IT 3.26B 64M
Xeris Pharmaceuticals Inc XERS:US $ 35.42M 725K
Zoetis ZTS:US $ 1.33B 19M